BPC-157 Neurological Research: Dopamine and Serotonin
Explore BPC-157 neurological research: dopaminergic, serotonergic, and GABAergic pathways, neuroprotection, and depression-like behaviour in rodent models.
Explore BPC-157 neurological research: dopaminergic, serotonergic, and GABAergic pathways, neuroprotection, and depression-like behaviour in rodent models.
Explore preclinical research on Selank and Pinealon neuropeptides: GABA-A modulation, epigenetic neuroprotection, and complementary rodent model findings.
Explore preclinical research on the CJC-1295 MOTS-c stack: GH axis amplification paired with mitochondrial AMPK activation across animal model studies.
Explore preclinical NAD+ Epithalon longevity research: sirtuin/PARP and telomere pathways, parallel aging hallmarks, and animal-model co-administration data.
TB-500 (Thymosin Beta-4) research documents actin sequestration, angiogenesis, and muscle, tendon, and cardiac repair in preclinical animal models. Full review.
Explore preclinical research on MOTS-c peptide, the mitochondrial-derived peptide encoded in 12S rRNA linked to glucose homeostasis and AMPK activation.
Preclinical research on Selank explores GABA-A modulation, anxiolytic effects in rodent stress models, and BDNF upregulation without dependence or tolerance.
Explore preclinical research on GHK-Cu copper peptide, covering collagen synthesis, wound healing models, anti-fibrotic signaling, and gene expression data.
Preclinical research on CJC-1295, a GHRH analog studied for GH pulse amplification, IGF-1 axis modulation, and body composition effects in animal models.
Explore preclinical and clinical research on Tesamorelin, a 44-amino acid GHRH analog studied for visceral adiposity, GH pulse dynamics, and metabolic markers.
THE STACK · RESEARCH NOTES
125 papers across 8 compound categories.